Molecules tremelimumab to zonisamide
34 molecules with a full cross-agency decision record, part of 534 published in total.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| tremelimumab | 9 | 5 | Antineoplastics |
| treosulfan | 9 | 6 | Antineoplastics |
| trientine | 14 | 5 | Other alimentary tract and metabolism |
| triptorelin | 17 | 4 | Endocrine therapy |
| tucatinib | 19 | 13 | Antineoplastics |
| ulipristal | 9 | 5 | Sex hormones and modulators |
| upadacitinib | 93 | 16 | Immunosuppressants |
| ustekinumab | 71 | 11 | Immunosuppressants |
| valganciclovir | 15 | 5 | Antivirals |
| valsartan | 18 | 5 | Renin-angiotensin system |
| vamorolone | 11 | 8 | Systemic corticosteroids |
| vandetanib | 11 | 7 | Antineoplastics |
| varenicline | 10 | 5 | Other nervous system |
| vedolizumab | 44 | 12 | Immunosuppressants |
| velmanase alfa | 15 | 11 | Other alimentary tract and metabolism |
| vemurafenib | 9 | 8 | Antineoplastics |
| venetoclax | 61 | 14 | Antineoplastics |
| vericiguat | 12 | 8 | Cardiac therapy |
| vestronidase alfa | 7 | 5 | Other alimentary tract and metabolism |
| vibegron | 10 | 9 | Urologicals |
| vildagliptin | 16 | 7 | Diabetes |
| vismodegib | 12 | 8 | Antineoplastics |
| volanesorsen | 9 | 8 | Lipid modifying agents |
| voriconazole | 20 | 7 | Antimycotics |
| vortioxetine | 8 | 6 | Psychoanaleptics |
| vosoritide | 14 | 8 | Bone diseases |
| vutrisiran | 27 | 15 | Other nervous system |
| zanamivir | 7 | 6 | Antivirals |
| zanubrutinib | 58 | 16 | Antineoplastics |
| zilucoplan | 12 | 11 | Immunosuppressants |
| zirconium cyclosilicate | 8 | 6 | Other therapeutic products |
| zolbetuximab | 15 | 12 | Antineoplastics |
| zoledronic acid | 16 | 4 | Bone diseases |
| zonisamide | 14 | 6 | Antiepileptics |